Open AccessSystemic Vasculitis Following SARS-CoV-2 mRNA Vaccination Demonstrated on FDG PET/CT
Author(s) -
Koya Nakatani,
Etsuro Sakata,
Masakazu Fujihara,
Kaoru Mizukawa,
Takashi Koyama
Publication year - 2022
Publication title -
clinical nuclear medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.637
H-Index - 57
eISSN - 1536-0229
pISSN - 0363-9762
DOI - 10.1097/rlu.0000000000004115
Subject(s) - medicine , covid-19 , vaccination , vasculitis , virology , pathology , outbreak , disease , infectious disease (medical specialty)
Causality regarding adverse events following SARS-CoV-2 mRNA vaccine is undetermined for vasculitis. Herein, we report the case of an 80-year-old man who presented with a persistent high fever of 7 days' duration that began shortly after receiving a COVID-19 vaccination. There was also a complaint of persistent lower limb pain and walking difficulty on emergency transportation. FDG PET/CT demonstrated extensive linear hypermetabolic foci along the vessels of both legs, including the hips, and the arms, supraclavicular area, chest wall, and temporal regions, suggesting systemic vasculitis. Subsequent temporal artery biopsy revealed arteritis, which is not typical of giant cell arteritis.